| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 8.34e-05 | 473 | 45 | 7 | GO:0004842 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | 1.36e-04 | 512 | 45 | 7 | GO:0019787 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.73e-04 | 532 | 45 | 7 | GO:0016755 | |
| GeneOntologyMolecularFunction | acyltransferase activity | 2.99e-04 | 775 | 45 | 8 | GO:0016746 | |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 4.44e-04 | 14 | 45 | 2 | GO:0034450 | |
| GeneOntologyCellularComponent | ubiquitin ligase complex | 1.02e-04 | 352 | 45 | 6 | GO:0000151 | |
| Domain | Ufd2P_core | 5.93e-06 | 2 | 46 | 2 | PF10408 | |
| Domain | Ub_conjug_fac_E4_core | 5.93e-06 | 2 | 46 | 2 | IPR019474 | |
| Domain | U_BOX | 1.24e-04 | 7 | 46 | 2 | PS51698 | |
| Domain | Ubox | 1.65e-04 | 8 | 46 | 2 | SM00504 | |
| Domain | U-box | 1.65e-04 | 8 | 46 | 2 | PF04564 | |
| Domain | Ubox_domain | 2.64e-04 | 10 | 46 | 2 | IPR003613 | |
| Domain | - | 2.14e-03 | 222 | 46 | 4 | 1.25.10.10 | |
| Domain | ARM-like | 4.33e-03 | 270 | 46 | 4 | IPR011989 | |
| Domain | ARM-type_fold | 9.55e-03 | 339 | 46 | 4 | IPR016024 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.07e-10 | 208 | 46 | 8 | 33230847 | |
| Pubmed | 6.14e-07 | 13 | 46 | 3 | 29499138 | ||
| Pubmed | A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. | 1.71e-06 | 2 | 46 | 2 | 10089879 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 39125645 | ||
| Pubmed | Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export. | 1.03e-05 | 4 | 46 | 2 | 25201882 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 18195045 | ||
| Pubmed | 1.20e-05 | 225 | 46 | 5 | 12168954 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 1.22e-05 | 1105 | 46 | 9 | 35748872 | |
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 23038782 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 11802788 | ||
| Pubmed | HiQuant: Rapid Postquantification Analysis of Large-Scale MS-Generated Proteomics Data. | 2.56e-05 | 6 | 46 | 2 | 27086506 | |
| Pubmed | Oxysterol Restraint of Cholesterol Synthesis Prevents AIM2 Inflammasome Activation. | 4.77e-05 | 8 | 46 | 2 | 29033131 | |
| Pubmed | Caspase-11 activation requires lysis of pathogen-containing vacuoles by IFN-induced GTPases. | 6.12e-05 | 9 | 46 | 2 | 24739961 | |
| Pubmed | BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation. | 6.12e-05 | 9 | 46 | 2 | 30704900 | |
| Pubmed | U box proteins as a new family of ubiquitin-protein ligases. | 7.65e-05 | 10 | 46 | 2 | 11435423 | |
| Pubmed | Guanylate binding proteins promote caspase-11-dependent pyroptosis in response to cytoplasmic LPS. | 9.34e-05 | 11 | 46 | 2 | 24715728 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.04e-04 | 184 | 46 | 4 | 32908313 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 1.04e-04 | 1455 | 46 | 9 | 22863883 | |
| Pubmed | 1.12e-04 | 12 | 46 | 2 | 29459437 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 1.20e-04 | 588 | 46 | 6 | 38580884 | |
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 19624305 | ||
| Pubmed | Interaction of U-box-type ubiquitin-protein ligases (E3s) with molecular chaperones. | 1.32e-04 | 13 | 46 | 2 | 15189447 | |
| Pubmed | 1.78e-04 | 15 | 46 | 2 | 25774716 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.78e-04 | 398 | 46 | 5 | 35016035 | |
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 21292315 | ||
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 27760317 | ||
| Pubmed | Evidence for distinct functions for human DNA repair factors hHR23A and hHR23B. | 2.58e-04 | 18 | 46 | 2 | 16712842 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 2.67e-04 | 94 | 46 | 3 | 23431145 | |
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 3.21e-04 | 247 | 46 | 4 | 32989298 | |
| Pubmed | ETAA1 acts at stalled replication forks to maintain genome integrity. | 3.54e-04 | 21 | 46 | 2 | 27723720 | |
| Pubmed | 3.80e-04 | 106 | 46 | 3 | 18654987 | ||
| Pubmed | A functional cellular framework for sex and estrous cycle-dependent gene expression and behavior. | 4.25e-04 | 23 | 46 | 2 | 35065713 | |
| Pubmed | 4.27e-04 | 1049 | 46 | 7 | 27880917 | ||
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 4.99e-04 | 498 | 46 | 5 | 36634849 | |
| Pubmed | 5.04e-04 | 25 | 46 | 2 | 35139355 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 5.21e-04 | 281 | 46 | 4 | 28706196 | |
| Pubmed | 6.33e-04 | 28 | 46 | 2 | 24880616 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | 6.77e-04 | 1489 | 46 | 8 | 28611215 | |
| Pubmed | 8.54e-04 | 140 | 46 | 3 | 26930384 | ||
| Pubmed | 8.80e-04 | 33 | 46 | 2 | 25064009 | ||
| Pubmed | 1.30e-03 | 162 | 46 | 3 | 23012479 | ||
| Cytoband | 1p34.2 | 1.51e-03 | 57 | 46 | 2 | 1p34.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p34 | 3.22e-03 | 294 | 46 | 3 | chr1p34 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p22 | 4.93e-03 | 104 | 46 | 2 | chr2p22 | |
| GeneFamily | U-box domain containing | 4.83e-05 | 7 | 28 | 2 | 365 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 3.10e-04 | 17 | 28 | 2 | 1291 | |
| ToppCell | BL|World / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-06 | 197 | 46 | 5 | 1acf0191fa0a25cd20bfd9ea7bf727a1555986a1 | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.35e-05 | 162 | 46 | 4 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 3.86e-05 | 184 | 46 | 4 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 4.11e-05 | 187 | 46 | 4 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.11e-05 | 187 | 46 | 4 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.20e-05 | 188 | 46 | 4 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 4.20e-05 | 188 | 46 | 4 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.47e-05 | 191 | 46 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 46 | 4 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.65e-05 | 193 | 46 | 4 | 6e1498153a7766c03fddbda1701dbf1596d21736 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.65e-05 | 193 | 46 | 4 | fce4f805e53669acb4c188f87ac7d84408c0c218 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 4.84e-05 | 195 | 46 | 4 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.94e-05 | 196 | 46 | 4 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.94e-05 | 196 | 46 | 4 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.94e-05 | 196 | 46 | 4 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.94e-05 | 196 | 46 | 4 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-lymphocytic-T_lymphocytic-T_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.94e-05 | 196 | 46 | 4 | 4a880a5d2c7047c050c7d6dd62186f35dc5c01f7 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 199 | 46 | 4 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 691b3edf7d8449556e8bf611662eb85772959f0f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells-Neuroepithelial_cell|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 4e077aa7faddcebdfc54667f8b3990704441005b | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW08-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | d17ba4239e1fd702a3d757687110f0f2c6f91ef7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW08-Stem_cells-Stem_cells|GW08 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 36a110aa91a791fdf1142e7869e8aa0d342402d0 | |
| ToppCell | ASK440-Epithelial|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 5.34e-05 | 200 | 46 | 4 | cb617e2a0ca82b470b473b8d5906bc8879c85718 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.21e-05 | 78 | 46 | 3 | d5e2e2e04e380b265b2530e93cba6f98ad329e4f | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 3.65e-04 | 135 | 46 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-Treg|ICU-SEP / Disease, Lineage and Cell Type | 4.50e-04 | 145 | 46 | 3 | ee99b58462f955b96d036aa67e343db047d66f64 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.50e-04 | 145 | 46 | 3 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.68e-04 | 147 | 46 | 3 | 94998bc40f5c08295cfe3bdcbe43f13b1e564b3d | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 153 | 46 | 3 | 6a2a2379238133ce0ad714af130ffe02dd317247 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Granulocytic-Neutrophil|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.26e-04 | 153 | 46 | 3 | faa442dd925b2b09919e93c492ccc3f19803ad24 | |
| ToppCell | COVID-19_Moderate-multiplets|World / disease group, cell group and cell class | 5.56e-04 | 156 | 46 | 3 | afdc025fa75e7926b1cc182c4a33654a2186abb1 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-04 | 156 | 46 | 3 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 5.56e-04 | 156 | 46 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | T_cells-GNLY+GZMB+_T_cells|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.67e-04 | 157 | 46 | 3 | e9eb56a1dd96bd2e9725a20f2cf70ddeab811bd6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.88e-04 | 159 | 46 | 3 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.21e-04 | 162 | 46 | 3 | ca30d9bf61f4133566fdc91c7996e130ea554d01 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.32e-04 | 163 | 46 | 3 | 1feb4ef7b8abcfca9a72c8d13c40548de79e7db2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-04 | 163 | 46 | 3 | 4dfd408aa700e307478ee35f6b902f68719d8d9e | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 164 | 46 | 3 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 164 | 46 | 3 | 1cb5fbd7050650047ad6f2ca792118e98d58d22b | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.43e-04 | 164 | 46 | 3 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 164 | 46 | 3 | 1d0d88132baaa3154c3e6e4ef0aff795afab08a2 | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-04 | 164 | 46 | 3 | bd2e10b015d5e6a338675500ec5d81dc39583b3e | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-Tregs|bone_marrow / Manually curated celltypes from each tissue | 6.55e-04 | 165 | 46 | 3 | 1ae1ad4e1fe19b6eefff0f9a03d58a384f169759 | |
| ToppCell | PND14-Immune-Immune_Myeloid|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.55e-04 | 165 | 46 | 3 | e37d00084f58fbd25f66ee65be510c030167084e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-04 | 166 | 46 | 3 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | PND01-03-samps-Myeloid|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 6.66e-04 | 166 | 46 | 3 | 99dc8a186ec12d3563e81fa4618a814740332c73 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.78e-04 | 167 | 46 | 3 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-04 | 168 | 46 | 3 | e20e1936573fdde78426d7a4eb45c458d5c4dbb4 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.90e-04 | 168 | 46 | 3 | cc0dd43d5cda01e643d8e8d74ec7617d61890760 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 6.90e-04 | 168 | 46 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-B_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 6.90e-04 | 168 | 46 | 3 | 16b517e3159ad6e6d25fd48f7d5f46e77b2b318d | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-04 | 169 | 46 | 3 | c6750c45c44be68aea39e918ba97c6f875ccea34 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-04 | 169 | 46 | 3 | 1077fbca61bd0c1f9706aeb0552b77362127f261 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-04 | 169 | 46 | 3 | 70c841a7b1e3f665105d715a6d72762c80ce5de2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.02e-04 | 169 | 46 | 3 | 15d5758d94a14a909d1d0c8bba9ce497a33d1512 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.14e-04 | 170 | 46 | 3 | 7534ac69ca3a378df78d61c284e89bc96a71a4a8 | |
| ToppCell | normal-na-Lymphocytic_T-T4_em-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.26e-04 | 171 | 46 | 3 | 61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3 | |
| ToppCell | PND07-Immune-Immune_Myeloid|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.26e-04 | 171 | 46 | 3 | f68cbfa2eb1f39401a31dbd9b630023249406098 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 7.26e-04 | 171 | 46 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.39e-04 | 172 | 46 | 3 | cf46810dd1072b6f2171e5d9530351ddc79a055b | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-04 | 172 | 46 | 3 | e72966ced5f2ee9e24ce9fd820d99a69a482a607 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.39e-04 | 172 | 46 | 3 | 83730ea3b240b8e2f2a9fb6c34dd1408050867ff | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-CD4-positive,_alpha-beta_T_cell-CD4-positive,_alpha-beta_T_cell_l9|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.51e-04 | 173 | 46 | 3 | da0f1461643294f92e20b5e456a50211a2780a91 | |
| ToppCell | PND07-Immune-Immune_Myeloid-Monocytic-Macrophage|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | 985068b149489b731a305ea9a5cfce8eafc9d289 | |
| ToppCell | PND14-Immune-Immune_Myeloid-Monocytic-Macrophage|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | 34416c583eaa21ce447d9b67bb420e35d05acc25 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.51e-04 | 173 | 46 | 3 | 7713716ec95932b2fac177ce4cfec027b4754cef | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-ILCP|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-04 | 174 | 46 | 3 | c0204a0d0a979a489e8d30dc5396e99da14c119c | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.76e-04 | 175 | 46 | 3 | a8b05972e1bec4de73feaa6c4a9bcbe6b50c8044 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.76e-04 | 175 | 46 | 3 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.76e-04 | 175 | 46 | 3 | cc2428150987911d0d382e8177918724aa69f85c | |
| ToppCell | PND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.89e-04 | 176 | 46 | 3 | a9e77681bcd36c382d53eb6f771349d55f98d744 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.89e-04 | 176 | 46 | 3 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-04 | 177 | 46 | 3 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.02e-04 | 177 | 46 | 3 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.02e-04 | 177 | 46 | 3 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.02e-04 | 177 | 46 | 3 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 8.02e-04 | 177 | 46 | 3 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.16e-04 | 178 | 46 | 3 | 90dedb3cef9b01907b9f8eec64218d6d2072be1f | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-T4_reg|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.16e-04 | 178 | 46 | 3 | d6312286bf6cc5b107ccd7adb583d9667d4e1d21 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 8.29e-04 | 179 | 46 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-gdT|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.29e-04 | 179 | 46 | 3 | ab8d8104b38603ec7fbc5b35d7149e71ad57c43a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c12-FOXP3|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.42e-04 | 180 | 46 | 3 | 6bb9f41c3a99d1bbe697f589fb2bcea9b7bfbeee | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 8.42e-04 | 180 | 46 | 3 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 8.42e-04 | 180 | 46 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-04 | 180 | 46 | 3 | 023ec0b080c8a5cd0f36e83c6b17d4be3c01edb5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 8.42e-04 | 180 | 46 | 3 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | normal-na-Lymphocytic_NK-T_mait-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.42e-04 | 180 | 46 | 3 | e66a8a61b3576ac37de7c559d16d4ed4f7a2fc78 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-04 | 180 | 46 | 3 | 788d5fbf688365b5d92d3aa19b9f8e9448f8be5a | |
| ToppCell | AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 8.56e-04 | 181 | 46 | 3 | ed0ea67f0607073aedf153f8d1073b35e46127c3 | |
| ToppCell | COVID-19_Severe-Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 8.56e-04 | 181 | 46 | 3 | 5e5101195d5ff8c8ea7ddcf0bc4f4e03e64c01e0 | |
| ToppCell | COVID-19_Severe-Neutrophil|COVID-19_Severe / Disease condition and Cell class | 8.56e-04 | 181 | 46 | 3 | aa5e5fb0308b5e2ef918548c85529c9a433c57f5 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.70e-04 | 182 | 46 | 3 | eb4be1c02b8b033d025e57b8b4cdbfaec4698054 | |
| ToppCell | NS-moderate-d_07-13-Myeloid-Monocyte-derived_Macrophage|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.70e-04 | 182 | 46 | 3 | e03e995e5fd14fc6a7559b83c0ca4e7ccc8e3d0f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-04 | 182 | 46 | 3 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | FLU-Healthy-0|FLU / Virus stimulation, Condition and Cluster | 8.84e-04 | 183 | 46 | 3 | 058604ddb06b3bef131183d86b83b422dae8f6cb | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.84e-04 | 183 | 46 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CXCL9+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.84e-04 | 183 | 46 | 3 | 99a36e9c74346b619b3b87d8d6bbf9b4b797c821 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.84e-04 | 183 | 46 | 3 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 8.84e-04 | 183 | 46 | 3 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| Drug | Terconazole [67915-31-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 2.65e-06 | 196 | 46 | 6 | 2844_DN | |
| Drug | nicotinuric acid | 1.20e-05 | 3 | 46 | 2 | CID000068499 | |
| Disease | insulin sensitivity measurement, response to polyunsaturated fatty acid supplementation | 1.24e-04 | 11 | 45 | 2 | EFO_0004471, EFO_0009131 | |
| Disease | Neurobehavioral Manifestations | 1.49e-04 | 12 | 45 | 2 | C0525041 | |
| Disease | cutaneous squamous cell carcinoma | 1.17e-03 | 33 | 45 | 2 | EFO_1001927 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 1.39e-03 | 36 | 45 | 2 | EFO_0006325 | |
| Disease | Developmental delay (disorder) | 1.46e-03 | 37 | 45 | 2 | C0424605 | |
| Disease | coffee consumption measurement | 2.71e-03 | 182 | 45 | 3 | EFO_0006781 | |
| Disease | non-high density lipoprotein cholesterol measurement | 4.47e-03 | 713 | 45 | 5 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NNQKLMAQVLCELFQ | 3776 | Q9NR09 | |
| MECQTALQKTQLQLQ | 101 | Q6P9F0 | |
| QLQNSNITRANCNKM | 381 | Q9NY47 | |
| SNNRECIMQNNKFLV | 881 | Q9UK96 | |
| LKQNINICLYMNQLP | 316 | Q96M93 | |
| CQLKKQNMLLQQQLD | 1721 | A6QL64 | |
| TKNNNQTANMCRFLL | 186 | P32238 | |
| FQNQIMKLENCVQAN | 536 | A6NI56 | |
| FVRLFQKQLLQMCQS | 501 | Q8IWY9 | |
| LQDQCQQNLVMQVLK | 206 | Q9H2T7 | |
| QQNLVMQVLKLVLNC | 211 | Q9H2T7 | |
| DCAKQMQVLLAQVQN | 326 | Q9H5N1 | |
| NPQNKAARLQISMCQ | 381 | Q13451 | |
| NGMTNQSKNCFQLIL | 21 | Q7Z353 | |
| QNQMLSALFQQKLQL | 96 | Q9HCH0 | |
| LFKNLIQNMNNIISF | 111 | O43150 | |
| SLQKALQQCELVQNM | 16 | Q6VAB6 | |
| QNAKQALRNMINSSC | 1971 | Q96RV3 | |
| LLHKNQQLTMQVACL | 646 | Q1X8D7 | |
| SNIMEQKDQQFLNLC | 681 | Q5S007 | |
| SASKLLQNLAQCGMQ | 626 | P48552 | |
| MCLIENFNEQLKVNQ | 11 | Q96PP8 | |
| MKNSQILSQFNQNCI | 826 | Q9NY74 | |
| LQQKSQIIVMLTQCN | 1026 | Q16827 | |
| LQNGCMNRFKNALNS | 1881 | Q9P2D3 | |
| LQLNAIFNMLNTKNC | 256 | P29466 | |
| LNQDMTCTKNPQNLN | 736 | Q4AC94 | |
| KNNKCQLILQNNIEM | 1286 | P51587 | |
| NCIGKQFAMNQLKVA | 456 | Q5TCH4 | |
| QKVQQFFRLCQQSMD | 846 | O95886 | |
| QNEMCLATQQLSKQL | 51 | Q8NEU8 | |
| AQKQIQSLNKMCSNL | 136 | Q96G25 | |
| QCQQLQMFFLLLARE | 1001 | Q5T011 | |
| LVLDNCINKMVNNLS | 451 | O76064 | |
| MQCQDFHQLSQNLLL | 6661 | Q8WXH0 | |
| LCNIVFNSQMAQQLS | 121 | Q9NVN3 | |
| LLCNIMFFNLNRQEQ | 1401 | Q9NTG1 | |
| MIQQLVAAQLQCNKR | 226 | P55055 | |
| SQQFVELINKCNSMQ | 131 | Q12846 | |
| QTRINLNCTQKALMQ | 206 | Q9GZT8 | |
| VINFAQNKAMKCLQN | 1511 | O15027 | |
| QRNLNTDICLKNMAF | 61 | Q9BSJ1 | |
| RLAAMLNFNLQQLCG | 1116 | O95155 | |
| QAAAMQLSQCAKNLA | 1016 | Q9Y4G6 | |
| LQNCLNLQVSMAVLL | 581 | Q14139 | |
| LQNTMINLGLQNACD | 96 | P06737 | |
| QKMNLLRQQNLFCDV | 21 | Q15916 |